Monsanto Co. (NYSE:MON) Receives Average Recommendation of “Buy” from Analysts
Monsanto Co. (NYSE:MON) has been assigned an average rating of “Buy” from the twenty-seven ratings firms that are presently covering the firm. Two equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation, fifteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $112.97.
A number of analysts recently weighed in on the stock. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $127.00 price objective (up previously from $95.00) on shares of Monsanto in a report on Monday, June 13th. Argus reaffirmed a “buy” rating and issued a $128.00 price objective (up previously from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $122.43 price objective on the stock in a report on Tuesday, August 9th. Goldman Sachs Group Inc. set a $92.00 price objective on shares of Monsanto and gave the stock a “sell” rating in a report on Monday, June 27th. Finally, JPMorgan Chase & Co. raised shares of Monsanto from a “neutral” rating to an “overweight” rating and set a $128.00 price objective on the stock in a report on Wednesday, September 21st.
In other news, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in MON. Candriam Luxembourg S.C.A. purchased a new position in Monsanto during the second quarter worth approximately $12,767,000. Nisa Investment Advisors LLC raised its position in Monsanto by 3.2% in the second quarter. Nisa Investment Advisors LLC now owns 189,692 shares of the company’s stock worth $19,616,000 after buying an additional 5,890 shares in the last quarter. Shell Asset Management Co. raised its position in Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares in the last quarter. Carmignac Gestion purchased a new position in Monsanto during the second quarter worth approximately $197,555,000. Finally, Legal & General Group Plc raised its position in Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock worth $170,663,000 after buying an additional 46,878 shares in the last quarter. 79.02% of the stock is currently owned by institutional investors.
Shares of Monsanto (NYSE:MON) traded up 0.930% during mid-day trading on Wednesday, hitting $102.555. 2,626,345 shares of the company’s stock traded hands. Monsanto has a 1-year low of $83.73 and a 1-year high of $114.26. The stock has a market cap of $44.88 billion, a P/E ratio of 45.139 and a beta of 1.19. The stock has a 50 day moving average price of $104.97 and a 200-day moving average price of $101.31.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The company had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same period last year, the firm posted ($0.19) EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities research analysts anticipate that Monsanto will post $4.46 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 2.11%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is presently 89.26%.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.